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In May 2011, the Canadian Conference on Epigenetics
Epigenetics Eh! was held in London, Canada. The objectives of
this conference were to showcase the breadth of epigenetic
research on environment and health across Canada and
to provide the catalyst to develop collaborative Canadian
epigenetic research opportunities, similar to existing
international epigenetic initiatives in the US and Europe.
With ten platform sessions and two sessions with over 100
poster presentations, this conference featured cuttingedge epigenetic research, presented by Canadian and
international principal investigators and their trainees in the
field of epigenetics and chromatin dynamics. An EpigenART
competition included ten artists, creating a unique opportunity
for artists and scientists to interact and explore their individual
interpretations of this scientific discipline. The conference
provided a unique venue for a significant cross-section of
Canadian epigenetic researchers from diverse disciplines to
meet, interact, collaborate and strategize at the national level.

remodeling and non-coding RNAs). In the broader context, the
field of epigenetics includes the study of chromatin modifications that affect how, when and where genes are expressed, the
molecular machinery necessary for establishment and maintenance of context-specific epigenetic profiles, and the biochemical and structural underpinnings of chromatin organization in
the nucleus.1 Epigenetics impacts virtually all aspects of health
and disease, and every stage of the life cycle from gametogenesis,
to the embryo and fetus, and through childhood to adulthood.2
Importantly, epigenetically regulated genes and pathways have
emerged as the source of promising drug targets for numerous
diseases, including but not limited to cancer, central nervous system disorders, diabetes and inflammatory diseases.3,4
The opening keynote lecture of the conference was presented
Wednesday evening by Dr. Gary Felsenfeld (National Institute
of Diabetes and Digestive and Kidney Diseases; Bethesda, MD).
Dr. Felsenfeld set the scientific tone for the meeting with an
elegant presentation on chromatin boundaries, insulators and
long-term interactions in the nucleus. Dr. Felsenfeld discussed
the role of dicer/Ago2 in maintaining heterochromatic features
at a 16-kb genomic region located within the chicken beta-globin
locus. Dr. Felsenfeld also presented evidence that the insulator
protein CTCF binds to the SA2 component of the cohesin ring
as well as p68/SRA. Cohesin-CTCF interactions are stabilized
by p68 binding to both proteins, which ensures loop stabilization
and proper insulator activity.5,6 Finally, he presented work related
to CTCF-mediated long-range interactions at the insulin gene.
Using 4C analysis, they have identified a novel, glucose-dependent interaction between the insulin and Syt8, a gene involved in
the regulation of insulin secretion.
The first day of talks was kicked-off with a session on
Epigenetic Processes in Development and Disease. Dr. Yi Sun
(University of California, Los Angeles) presented evidence that
the de novo DNA methyltransferase 3A (DNMT3A) is required
for neuronal differentiation of adult neural stem cells (NSCs).
By mapping genome-wide DNMT3A occupancy in postnatal
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The Canadian Conference on Epigenetics Epigenetics Eh! (i.e.,
Environment and health) was held in London, Ontario (May
4–7, 2011). The first of its kind in Canada, the conference was a
long-awaited event and attracted over 230 scientists and trainees
not only from Canada but also from seven other countries. With
34 platform and over 100 poster presentations, the conference
showcased the comprehensive nature of epigenetics and chromatin research, both in Canada and internationally.
Epigenetics is one of the most rapidly growing areas in biomedical research. The term “epigenetics” refers to heritable changes to
DNA that occur without changes in the nucleotide sequence (e.g.,
through DNA methylation, histone modifications, chromatin
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NSCs, her group found that genes functionally related to neurogenesis were significantly enriched within “high” H3K4me3DNMT3A targets, whereas genes involved in development
of non-neuronal lineage were enriched in “low” H3K4me3DNMT3A targets. Furthermore, they found that DNMT3A
mediates repression in self-renewing postnatal NSCs by methylating proximal promoters. Dr. Sun reported that, surprisingly,
DNMT3A can also promote transcription of neurogenic genes
by antagonizing Polycomb repression with non-proximal promoter methylation, running interference to polycomb repressor binding.7 Next, Dr. Art Petronis (CAMH/University of
Toronto) discussed his work on the epigenetics of complex traits
and diseases. Using in silico SNP analyses, his work suggests
that molecular mechanisms of heritability may not be limited to
DNA sequence differences.8 He hypothesized that epigenetic discordance in dizygotic twins is due to epigenomic differences in
the zygotes. Such epigenetic effects may be important contributors to neuropsychiatric disorders such as bipolar disorder. Using
genomic fine-mapping procedures, the Petronis lab found agerelated, locus-specific increases in DNA methylation, including
at the HLA complex group 9 gene in two bipolar postmortem
brain samples.9 The final talk of this session was by Dr. Wendy
Robinson (University of British Columbia), who discussed epigenetic mechanisms of placenta-associated disease. Using whole
genome approaches and targeted methylation studies, her group
observed significant methylation differences in abnormal placentae associated with intrauterine growth retardation (IUGR)
and maternal preeclampsia, that were greater than within and
between group DNA methylation variation in control placentae.10
The rapidly advancing area of Non-coding RNAs was
featured in the second session. Dr. Rob Martienssen (Cold
Spring Harbor Laboratories) described his work on the
inheritance of heterochromatin silencing in the fission yeast
Schizosaccharomyces pombe via the RNA interference pathway.
Transcription of heterochromatin takes place during a narrow window in S-phase at a time when the genome is being
replicated. He reported that the RNAi pathway is required to
stall replication forks in heterochromatin and evict DNA Pol
II. This complex process further involves centromere-binding
protein B, which is required for RNAi-induced fork stalling.11
In the absence of RNAi, DNA repair mechanisms are required
to remove DNA Pol II from replication forks. Next, Dr. Carolyn
Brown (University of British Columbia) gave an update on her
work on X-chromosome inactivation. Using an inducible XIST
transgene system, her lab has been able to dissect how this noncoding RNA (ncRNA) is localized to, and silences, cis-linked
DNA. Her group has shown that a reporter gene is reversibly
inactivated by an inducible XIST transgene. This regulation is
dependent on XIST RNA secondary structure and its multimeric
A repeats, but independent of PRC2 function or H3K27me3
recruitment.12 Finally, Dr. Patrick Provost (Université Laval)
discussed the role of microRNAs, guided RNA and human disease. He presented data suggesting that suboptimal assembly of
miRNAs and their targets may contribute to molecular defects
in Fragile X patients. Similarly, miRNA dysregulation may provide the molecular basis for the misregulation of beta-amyloid

precursor protein-converting enzyme in Alzheimer’s Disease.13
Additional work from his laboratory shows that human platelets
act as a circulating source of a rich and diverse set of miRNAs
that may be relevant to stroke and acute coronary syndromes.14
Together, his work points to a significant role for the dysregulation of miRNA biogenesis and function in the etiology of a
number of human genetic diseases.
Next, a session on Chromatin Mechanisms in Epigenetic
Marking brought together four leaders in the field. A dynamic
presentation by Dr. Ali Shilatifard (Stowers Institute) provided
insight into chromosomal rearrangements and translocations
involving the mixed lineage leukemia (MLL) protein, a positively
regulator of HOX genes. His lab has shown that the yeast MLL
homolog Set1 is a component of the large COMPASS complex
that methylates histones in the early-transcribed region of genes.15
Using a global functional proteomic screen (Global Proteomic
analysis in S. cerevisiae), his lab has defined the molecular
machinery required for COMPASS function in histone methylation and transcriptional regulation. In addition, many translocation partners of MLL interact with each other within a large
macromolecular super elongation complex (SEC) that contains
known RNA polymerase II elongation factors.16 In mouse embryonic stem cells, SEC can lead to a rapid induction of genes with
paused Pol II. Dr. Juan Ausió (University of Victoria) then spoke
on the complex and critical roles of methyl CpG binding protein
2 (MeCP2) as a reader of multiple epigenetic marks. He showed
that MeCP2 binds to nucleosomes in a manner analogous to
linker histones, with binding specificity being strongly dependent
on DNA methylation, but independent of the core histone H3
N-terminal tail and histone acetylation.17 In brain tissue, most
of MeCP2 protein is associated with non-nucleosomal regions
while nucleosomal MeCP2 is associated with histone H2A.X
and a variety of histone post-translational modifications that may
regulate the functional activity of MeCP2. Thus, MeCP2 still
retains its intrinsic chromatin binding-repressive activity, but
operates as a regulatory switch for transcription.18 Dr. Jacques
Côté (Université Laval) discussed the multifunctional roles of
the highly conserved MYST family of eukaryotic histone acetyltransferases (HATs). These HATs carry out a significant proportion of all nuclear acetylation associated with transcriptional
chromatin dynamics, DNA repair and DNA replication.19 They
also have activities on non-nucleosomal targets that make them
fundamentally important to cell function and as potential targets
for new clinical therapies.20 Finally, Dr. Jim Davie, (Manitoba
Institute of Cell Biology/University of Manitoba) also bridged
the basic biology of epigenetic pathways and clinical therapies by
discussing the roles of histone deacetylases (HDACs) as regulators of steady state levels of protein acetylation. In its non-phosphorylated form, HDAC2 binds to the coding region of genes in a
transcription dependent manner, while phosphorylated HDAC2
is localized to promoters. HDAC inhibitors prevent induction by
preventing loading of RNA Pol II, thereby blocking transcription. As well, he discussed the mechanism of MSK1-induced
chromatin remodeling at immediate-early gene regulatory elements as a potential target for cancer chemotherapy in clinical
cases with an activated RAS-MAPK pathway.21
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The final session of the conference’s first full day focused on
Nuclear Dynamics and Long Range Control. Dr. Frank Grosveld
(Erasmus University Medical Centre) opened the session with a
talk focused on an experimental pipeline integrating the function
and composition of multiprotein transcription factor complexes
with their target gene sequences and their roles in mediating
long-range interactions on the chromatin fiber.22 Specific roles for
complexes involving the adaptor protein LDB1 (LIM domainbinding protein 1) establish this as a positive regulator of the
final steps of erythroid differentiation.23 Dr. Jennifer Mitchell
(University of Toronto) then spoke about her work focusing on
nuclear genome organization and its influence on gene expression. Genome-wide analyses in erythroid tissues show that active
globin genes associate with hundreds of other transcribed genes,
revealing extensive and preferential intra- and inter-chromosomal
transcription interactomes.24 Using a genome-wide 3C approach,
she reported that an inter-chromosomal interaction network is
co-regulated by GATA-1, KLF1 and TAL1. She proposed that
such three-dimensional organization dictates coordinated gene
expression through the clustering of co-regulated genes at specific transcription factories. Finally, Dr. Hassan Ismail (from
Dr. Michael Hendzel’s laboratory at the University of Alberta)
finished the session with a presentation on Polycomb group
(PcG) proteins and their recruitment to sites of DNA damage.
The recruitment of the polycomb repressive complex 1 proteins
BMI1 and RING2 to sites of DNA double-strand breaks (DSBs)
contributes to the ubiquitylation of γH2AX.25 With the loss of
BMI1, several proteins that are dependent on ubiquitin signaling
are impaired in their recruitment to DSBs and cells are sensitized to ionizing radiation. This newly identified link between
the PcG proteins and the DNA damage response pathway points
to a novel function for BMI1 in genomic stability that is broader
than its documented function as a transcriptional repressor.
The second full day of the conference began with the Epigenetics
and the Environment session. Dr. Pat Hunt (Washington State
University) described her work on the recombination effects of the
endocrine disruptor bisphenol A (BPA) on mammalian reproduction. She showed that environmentally-relevant BPA levels caused
numerous meiotic effects in mouse oocytes that were likely due
to effects on the early oocyte, through interference with estrogen
receptor β function.26 BPA was also found to have effects on male
gametogenesis. Along with her other studies using rhesus monkeys, Dr. Hunt’s work suggests that the adverse impacts of BPA on
gametogenesis and fertility may be equally relevant to humans.
Dr. Patrick McGowan (University of Toronto) next discussed
environmentally induced epigenetic changes in the developing
brain and their effects. He showed that hypermethylation of the
rRNA promoter and its 5'-regulatory region in hippocampal tissue of brains from suicide subjects supports the hypothesis that
epigenetic differences at critical loci in the brain are involved in
the pathophysiology of suicide. From a more recent study using
a rat model, McGowan showed that an epigenetic response to
maternal care (or lack thereof) is coordinately regulated in clusters across broad genomic regions of chromosome 18 that include
the glucocorticoid receptor NR3C1 gene.27,28 Taken together,
his work proposes the provocative concept that an epigenomic

response to social adversity exists that can lead to gene-specific,
phenotypic and behavioral changes in disadvantaged individuals. Dr. Igor Kovalchuk (University of Lethbridge) finished the
session on a decidedly different note, focused on environmental
epigenetic phenomena in plants. He showed how plant progeny
exhibit transgenerational effects from environmental exposures
in the form of an adaptive response to pathogens (i.e., viruses).
These effects coincide with global genome hypermethylation as
a general protection mechanism against stress, as well as locusspecific hypomethylation associated with a higher frequency of
rearrangements.29 The contribution of environmental stresses
thus can lead to genome evolution whereby epigenetic changes
precede genetic change.
The next session on Epigenetics and Cancer featured three
speakers who incorporate genome-wide studies into their
research. Dr. Peggy Farnham (University of Southern California)
described her work to define the distinct histone modifications
associated with the regulation of classes of transcription factors
required to translate genomic information into cell-specific phenotypes. Histone marks (H3K27me3 and H3K9me3) are present
over large genomic regions, requiring the involvement of DNA
binding factors and accessory proteins that can provide binding
specificity for members of the Zinc-finger family (ZNF) of transcription factors.30 She used genome-scale ChIP-chip and ChIPseq to demonstrate that the SETDB1 histone methyltransferase
(HMT), but not G9a HMT, is associated with regions enriched
for H3K9me3. Furthermore, SETDB1 is recruited to specific
genomic locations via interaction with the co-repressor KAP1,
which in turn is recruited via interaction with ZNFs that contain a
Kruppel-associated box (KRAB) domain.31 Other work from her
laboratory suggests that most gene expression changes mediated
by 5-azacytidine treatment are indirect, via altered H3K9me3
(but not H3K36me3) patterns that change chromatin accessibility. Next, Dr. Olga Kovalchuk (University of Lethbridge)
talked about indirect, non-targeted effects on cells exposed to
ionizing radiation and the disruption of DNA methylation and
microRNA expression in the germline and progeny of exposed
parents. Using a mouse model, they found that paternal irradiation leads to upregulation of the miR-29 family in the exposed
male germline, decreased DNMT3A expression and global
hypomethylation (particularly at repetitive LINE1 and SINE
B2 elements), as well as decreased levels of the lymphoid-specific
helicase (LSH).32 Changes in miR-709 also lead to decreased
expression of BORIS in the exposed testis. Furthermore, a significant upregulation of miR-468 decreases LSH expression in
thymus in the progeny of exposed parents.32,33 Thus, altered
microRNA expression and hypomethylation negatively impacts
genome stability of the parental germline and in subsequent
progeny. Finally, the effectiveness of integrating multiple pathways for gene discovery in cancer was the major topic of Dr. Wan
Lam’s presentation (University of British Columbia). Integrating
data sets from high density microarrays in various formats (DNA
methylation, histone modification, gene expression, gene copy
number, along with miR expression) is more complex than single
platform analyses, but permits the identification of genes that are
commonly disrupted by numerous pathways or are disrupted in
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low frequency on individual platforms, but common across multiple datasets.34
The second session on Epigenetic Processes in Development
and Disease featured speakers whose talks spanned a number of
human syndromes. Dr. Art Beaudet (Baylor College of Medicine)
discussed roles for epimutations as contributors to complex syndromes, using genome-wide analyses of DNA methylation in
normal and autism cerebellum samples and normal and schizophrenia cortical tissues. Hypermethylated CpG islands associated with individual gene loci (SERHL in one autism patient and
LOC652276 in one schizophrenia case) were contrasted with
unmethylated GpGs in controls. Furthermore, the presence of
hypermethylated and unmethylated clones in these patient samples was consistent with allele-specific methylation as a mechanism for haploinsufficiency. Significantly reduced transcript
levels from LOC652276 further suggested the co-occurrence of
an epimutation along with a mutation affecting the second allele,
highlighting epigenetic silencing as the functional equivalent of
a mutation-based loss of expression. Next, Dr. Nathalie Bérubé
(Children’s Health Research Institute/University of Western
Ontario) focused on the chromatin regulator ATRX that, when
mutated, causes an X-linked intellectual disability or cancer in
humans. Her group has shown that depletion of this chromatin
remodeling factor in human somatic cells and neuroprogenitor
cells in the developing mouse brain causes mitotic abnormalities involving defects in sister chromatid cohesion.35 In addition,
ATRX is required for cohesin and CTCF occupancy at the H19
imprinting control region and for reduced expression from the
H19 maternal allele in the postnatal brain.36 Thus, ATRX can
play a dual role in cell division and gene regulation, and may
be required for developmental regulation of imprinted gene
expression in the brain. Dr. James Ellis (SickKids/University
of Toronto) then discussed his work modeling Rett Syndrome
(RTT) using mouse and patient-specific induced pluripotent
stem (iPS) cells. He has generated mouse Rett Syndrome iPS
cells possessing mutations in MeCP2, that can yield functional
neurons retaining an inactive X-chromosome in a non-random
pattern in vitro. His group has also reprogrammed RTT patient
fibroblasts. Importantly, X chromosome inactivation persists in
these lines, allowing for the establishment of isogenic, human
Rett Syndrome iPS (RTT-hiPS) cell lines that express either
the wild type or mutant allele of MECP2 from the same RTT
patient.37,38 Upon differentiation, mutant RTT-hiPS neurons
have reduced soma size compared with the control RTT-hiPS
neurons. His work has permitted the functional analysis of the
disease-related neurons that display disease-specific alterations in
their neurophysiology. The final speaker in the session was Dr.
Marjorie Brand (Ottawa Hospital Research Institute/University
of Ottawa), who described her work on the TAL1/SCL master
regulator of hematopoiesis that is required for erythroid differentiation. Ectopic expression of TAL1 has a causative role in T-cell
acute lymphoblastic leukemia. Using ChIP sequencing and gene
set enrichment analysis, her lab found 117 TAL1 targets that are
repressed in leukemic T cells. Furthermore, alternate binding
sites for TAL1 have been identified in leukemic T cells versus
erythroid cells. TAL1 binds to E-box motifs more frequently in

leukemic T cells, as well as at genomic locations rich in RUNX
and ETS recognition sites. She also showed that RUNX1/3 and
ETS1 are required for TAL1 binding in leukemic T cells, and
that TAL1 associates with the KDM6A histone demethylase
complex, providing insight into cell-specific gene regulation and
the mechanism by which TAL1 inhibits differentiation, leading
to oncogenesis.39
Continuing on the theme of epigenetics and health, the
Genomic Imprinting session brought together three leaders in
the field. Dr. Anne Ferguson-Smith (University of Cambridge)
shared recent findings on the paternally imprinted Dlk1 gene40
that encodes an atypical Notch ligand. A membrane-bound
Dlk1 isoform is expressed in neural stem cells (NSCs), and is
necessary to respond to a secreted form produced by the astrocyte
niche. Dlk1-deficient mice exhibit defects in post-natal neurogenesis within the subventricular zone, leading to a decrease in
mature neurons in the adult olfactory bulb. While imprinted in
other tissues, Dlk1 expression is biallelic in postnatal NSCs due
to the acquisition of DNA methylation at the germline-derived
imprinting control region. Expression of both the maternal and
paternal allele is necessary for the continued maintenance of
NSCs, since heterozygous mice also exhibit abnormal neurogenesis. These results suggest that the modulation of imprinted genes
within stem cell populations may offer an additional level of epigenetic regulation during development. Dr. Rosanna Weksberg’s
(SickKids/University of Toronto) discussed the molecular mechanisms involved in Beckwith-Wiedemann syndrome (BWS).41
These mechanisms include epigenetic and/or genetic alterations
that influence the relative contributions of parental alleles, in part
through the loss of methylation seen at the chromosome 11p15.5
KvDMR imprinting center (IC). In addition, she reported on
studies of BWS-associated children in the assisted reproductive technologies (ARTs) population. She presented a surprising
case of a child with neonatal BWS who developed Angelman
Syndrome features. This transition is likely due to loss of methylation at multiple imprinted genes. She went on further to show
that loss of methylation is not restricted to imprinted genes but
also occurs at non-imprinted genes, suggesting that ART may
lead to a failure of maintenance methylation during pre-implantation development. Dr. Jacquetta Trasler (McGill University/
Montreal Children’s Hospital Research Institute) examined
the effects of hormonal stimulation, maternal age and DNMT
deficiency on the transmission of DNA methylation patterns
from the oocyte to the offspring in a mouse model system. She
showed that superovulation perturbs maternally- and paternallyderived imprints in the offspring and/or placenta, suggesting
that hormonal stimulation affects oocyte quality.42 In contrast,
embryos and placentae from aged mothers exhibited preservation
of normal genome-wide and gene-specific methylation patterns,
including at imprinted loci.43 Using an oocyte-specific RNAi
approach, her group also assessed how DNMT3L affects the
acquisition of genomic methylation in oocytes. When depleted
to less than 10% normal levels, embryonic development and fertility were compromised, and imprinted genes methylated late
in oocyte development showed greater loss of methylation than
those with early methylation acquisition. Perturbing epigenetic
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imprinting events at sensitive times during oogenesis or early
development can have long-term impacts on embryo growth
and development. At the conference’s Friday evening banquet,
a plenary presentation was given by Dr. Trevor Archer (National
Institute of Environmental Health Sciences). He provided a comprehensive talk on the dynamic mechanisms by which chromatin
remodeling complexes and transcription factors function to regulate gene expression. His wide-ranging presentation focused on
the complex interactions among a myriad of regulatory protein
complexes, such as the BRG1 chromatin remodeling complex,
and also highlighted the potential of protein components in these
complexes as therapeutic targets for specific cancers and neurodegenerative diseases.44
The conference concluded Saturday morning with two exciting sessions on the future of epigenetics research. First, three
“New Investigators” provided insight on topics that spanned the
field of epigenetics. Dr. Josée Dostie (McGill University) discussed work using Chromosome Conformation Capture techniques (3C) datasets to predict chromatin loops at the human
HOX gene cluster. These clusters are organized into multiple
chromatin loops that are dependent on transcriptional activity.45
EZH2 was found to have only subtle effects on HOXA looping.
Using high resolution-3C datasets with 3D computer modeling, the insulator protein CTCF was identified as a mediator of
these chromatin contacts, through close proximity binding sites
that likely mediate DNA looping and the correct 3D architecture and expression of these Hox gene clusters. Dr. Matt Lorincz
(University of British Columbia) next described the important
roles of DNA methylation and histone methylation (H3K9me3)
in the transcriptional silencing of specific genes and repetitive
endogenous retroviral elements (ERVs) in mouse embryonic
stem cells. His lab has shown that targeted deletion of the H3K9specific lysine methyltransferase SETDB1 leads to loss of silencing at ERVs upon loss of H3K9me3.46 This re-repression is DNA
methylation-independent. Interestingly, up to 15% of genes
upregulated in SETDB1 deleted cells were near neighbors of
ERVs. Half of these genes were produced as chimeric transcripts
originating from promoter proximal ERVs.46 Dr. Mellissa Mann
(Children’s Health Research Institute/University of Western
Ontario) finished the session by describing her research related
to the effects of ARTs on genomic imprinting. She showed that
imprint maintenance mechanisms were disturbed by superovulation and by commercial media systems, and resulted in perturbation in imprinted methylation during pre-implantation
development.47,48 Surprisingly, acquisition of DNA methylation
in oocytes was unaffected by superovulation. Her work suggests
that both ARTs affect components of a common pathway to
maintain imprinting during pre-implantation development.
The Conference’s final session on Epigenomics and New
Technologies provided three remarkable presentations that
highlighted new technological approaches in epigenetic analysis. Dr. Paul Soloway (Cornell University) described new nanofluidic technologies under development that will permit single
molecule and single cell chromatin analysis of post-translational
modifications histone at the nucleosome level. “Single chromatin-molecule analysis at the nanoscale” screening could identify

multivariant histone states on single chromatin molecules as well
as identify and capture rare cells with unique post-translational
modifications profiles from a population of cells.49 Dr. Cheryl
Arrowsmith (Structural Genome Consortium/University of
Toronto) highlighted work to identify and develop small molecule, chemical probes for pharmacological inhibition of individual target proteins. A number of proteins comprising the
epigenetic machinery are presently being targeted with small
molecule ligands, such as the methyl-lysine binding domain
protein, L3MBTL3,50 and the histone methyltransferases G9a
and GLP.51 The G9a selective inhibitor UNC0638 reduced
global of H3K9me2 levels, reactivated ERVs and G9a-regulated
genes, and improved the efficiency of retrovirally generated iPS
cells. Dr. David Bazett-Jones (SickKids/University of Toronto)
finished the session with a nano-view of chromatin. Using electron spectroscopic imaging (ESI) analysis, his lab is examining
changes in chromatin structure at the nano-scale level of resolution. The development of elemental phosphorous and nitrogen maps of nuclear organization has permitted his group to
characterize the physical structure of heterochromatin domains.
They have found that in pluripotent cells of the early embryo,
chromatin displays a disperse architecture. This contrasts with
cells from extra-embryonic lineages where chromatin is compartmentalized, similar to somatic cells. He also showed that
mouse iPS cells must be reprogrammed from a compacted to
dispersed architecture. In somatic and partial mouse iPS cells,
H3K9me3 marked heterochromatin in highly compartmentalized 10 nm chromatin fibers, while fully programmed iPS cells
10 nm fibers are highly dispersed, like embryonic stem cells.52
His work also determined that the genome organization of constitutive heterochromatin is based on 10 nm chromatin fibers
and not 30 nm fibers.53
In addition to the scientific sessions, several other initiatives
were undertaken at the Canadian Conference on Epigenetics
to reach out to and inform the non-scientific community. First,
a Café Scientifique on Epigenetics (“You are what your grandmother ate!”) was presented to over 60 members of the public
at a local Art Gallery. The Café was hosted by Dr. Victor Han
(Children’s Health Research Institute/University of Western
Ontario), and featured an interactive session by Dr. David
Rodenhiser (Children’s Health Research Institute/University of
Western Ontario), Dr. Brenda Coomber (University of Guelph)
and Dr. Igor Kovalchuk (University of Lethbridge), who introduced epigenetics and discussed the importance of epigenetic
research within the context of environment and human health.
A second outreach program identified and engaged promising
Partners in Learning co-operative high school students. These
students attended and experienced the Conference as a way to
enhance and enrich their academic research training and assist
in making informed decisions about future careers in research.
Finally, the most unique component of the Conference was
EpigenART, a collaboration with the London Arts Council that
provided a dynamic showcase of art and science by artists from
London Ontario and region. A juried competition led to the selection of ten artists who used diverse media to explore the general
context of epigenetics, environment and health. Their creative
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works (see Fig. 1) were viewed in conjunction with the scientific
posters, resulting in an exciting atmosphere that included interactive dialogue among artists and scientists, and an atmosphere
of creativity and common synergy that was enjoyed by the conference attendees and artists alike.
Acknowledgments

Figure 1. “Undergo” by Charity Miskelly. This commissioned art piece
from the EpigenART competition was one of ten original art pieces exhibited at the Canadian Conference on Epigenetics in conjunction with
the scientific poster sessions. As described by the artist, Undergo is an
existential study of life that depicts the drawn line as the authentic signature of the individual existing in an infinite space. Further, the piece is
also a manifestation of the epigenome as a distinct and miniscule mark
with a crucial role in the universe.
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